RDY 15.37 (+1.65%)
US2561352038Drug ManufacturersDrug Manufacturers - Specialty & Generic

Dr Reddys Laboratories (RDY) Stock Highlights

15.37 | +1.65%
2024-12-21 01:00:03
Headquartered in India, Dr. Reddys Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the companys sales are well dispersed across North America, India, and other emerging markets.

Statistics

Range Today
15.35 15.55
Volume Today 2.05M
Range 1 Year
13.26 16.89
Volume 1 Year 271.25M
Range 3 Year
9.58 16.89
Volume 3 Year 831.39M
Range 10 Year
5.63 16.89
Volume 10 Year 3.2B

Highlights

Market Capitalization 12.74B (large)
Floating Shares 600.02M
Current Price 15.37
Price To Earnings 18.97
Price To Revenue 0.01
Price To Book 0.04
Earnings Per Share 0.79
Dividend Yield 0.63%
Dividend Per Share 0.1
Payout Ratio 12.04%

Performance

Latest +1.65%
1 Month +6.88%
3 Months -2.04%
6 Months +8.7%
1 Year +13.43%
3 Years +26.82%
5 Years +89.75%
10 Years +51.28%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.